Published in Medical Letter on the CDC and FDA, December 12th, 2010
The Supplement consists of one Editorial, three Commentaries and eleven Research Reports.
The objectivity of the articles differs substantially; one of the Commentaries could be classified as puffery and elements of the Editorial are on the edge. CRE has not reviewed the Research Reports in detail, but CRE has reviewed the most significant initiation/cessation studies identified by FDA.
With respect to the Supplement CRE concludes that the Editorial and Commentaries are merely hearsay and have no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA